Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ BEX1/BEX2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5100404
Description
Antibody detects endogenous levels of total BEX1/2.
BEX1/BEX2 belongs to the brain expressed X-linked gene family. The encoded protein interacts with the transcription factor LIM domain only 2 in a DNA-binding complex that recognizes the E-box element and promotes transcription. BEX1/BEX2 has been found to be a tumor suppressor that is silenced in human glioma. In breast cancer cells, this gene product modulates apoptosis in response to estrogen and tamoxifen, and enhances the anti-proliferative effect of tamoxifen. Multiple transcript variants encoding different isoforms have been found for this gene.
Specifications
BEX1/BEX2 | |
Polyclonal | |
Unconjugated | |
BEX1 | |
AA407839; AL024066; AU018692; BEX1; BEX2; Bex4; brain expressed gene 1; brain expressed X-linked 1; brain expressed X-linked 2; brain expressed, X-linked 1; brain-expressed X-linked protein 1; Brain-expressed X-linked protein 1 homolog; brain-expressed X-linked protein 2; Brain-expressed X-linked protein 2 homolog; DJ79P11.1; EG2RVC; expression gene 2 in rat visual cortex; hBex2; HGR74-h; ovarian granulosa cell 13.0 kDa protein hGR74; protein BEX1; Protein BEX2; protein hBex2; reduced expression 3; reduced expression protein 3; Rex3; REX-3 | |
Rabbit | |
Affinity chromatography | |
RUO | |
12069, 19716, 363498, 501625, 55859, 84707 | |
-20°C | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
Q3MKQ1, Q3MKQ2, Q9BXY8, Q9HBH7, Q9R224, Q9WTZ8 | |
BEX1, BEX2 | |
A synthesized peptide derived from human BEX2(Accession Q9BXY8), corresponding to amino acid residues M1-R50. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction